Please login to the form below

Not currently logged in

Publicis Healthcare Group appoints new chief financial officer

Nathalie Le Bos was previously the group’s Europe CFO


New York-headquartered Publicis Healthcare Communications Group (PHCG) has named Nathalie Le Bos as the group's new chief financial officer (CFO).

She takes over the role previously held by Ann Garreaud, who recently took up the position of global CFO for Publicis Worldwide in Paris.

In her new role, Le Bos will focus on strengthening the financial functions of the Publicis Groupe network, which manages healthcare brands including Digitas Health, Saatchi & Saatchi Health and Razorfish Healthware.

Previously based in Paris, Le Bos has seven years' experience working with the Publicis Groupe, most recently as CFO, Europe for PHCG. She also served as operations control director for Publicis Worldwide.

Prior to joining Publicis, she was worked for Omnicom Group at Tequila as CFO and for Havas Group in various roles.

“Nathalie was an outstanding CFO for our European operations during a challenging economy,” said Nick Colucci, president and CEO of PHCG.

“I am fortunate to have her join my executive leadership team at the PHCG global headquarters. Her unique perspective and experience will prove invaluable as we continue to increase profitability and efficiencies for our clients across the globe."

Commenting on her appointment, Le Bos said: "PHCG continues to transform itself to ensure we offer the very best to our global clients.  

“I look forward to working closely with Nick and the rest of the leadership team to continue PHCG's strong financial performance."

21st January 2013

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?